Rational Design of Lipids & LNPs for mRNA Vaccines

Time: 4:30 pm
day: Day 2 PM


  • Rationally designed ionizable lipids that induce up to 20-fold neutralizing antibodies compared to clinically relevant mRNA vaccines for infectious diseases
  • Novel ionizable lipids and LNPs for superior efficacy in tumor models
  • Method to address manufacturing challenges of LNPs to improve mRNA vaccine accessibility